BETAHISTINE-ZP betahistine dihydrochloride 16mg tablets blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

betahistine dihydrochloride, Quantity: 16 mg

Disponibbli minn:

Medis Pharma Pty Ltd

INN (Isem Internazzjonali):

betahistine dihydrochloride

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: crospovidone; lactose monohydrate; povidone; stearic acid; colloidal anhydrous silica; microcrystalline cellulose

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

100 tablets, 25 tablets, 10 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Sommarju tal-prodott:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B16 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2015-11-10